Nordea Investment Management Ab Novo Cure LTD Transaction History

Nordea Investment Management Ab

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	SELL	$56.44 - $118.81 $8,409 - $17,702	-149 Reduced 2.71%	5,347 $321,000
Q4 2022 Feb 08, 2023	SELL	$63.98 - $85.37 $62,252 - $83,065	-973 Reduced 15.04%	5,496 $403,000
Q3 2022 Oct 19, 2022	BUY	$67.99 - $89.57 $68,941 - $90,823	1,014 Added 18.59%	6,469 $503,000
Q2 2022 Aug 09, 2022	SELL	$56.6 - $89.9 $30,167 - $47,916	-533 Reduced 8.9%	5,455 $383,000
Q3 2021 Nov 01, 2021	SELL	$116.17 - $194.55 $695,625 - $1.16 Million	-5,988 Reduced 50.0%	5,988 $695,000
Q3 2021 Nov 01, 2021	BUY	$116.17 - $194.55 $695,625 - $1.16 Million	5,988 Added 100.0%	11,976 $1.39 Million
Q2 2021 Jul 16, 2021	BUY	$130.4 - $225.58 $270,449 - $467,852	2,074 Added 52.99%	5,988 $1.33 Million
Q4 2020 Feb 12, 2021	BUY	$112.16 - $174.14 $438,994 - $681,583	3,914 New	3,914 $677,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.79B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

Stay updated on Nordea Investment Management Ab with notifications on news.